European Psychiatry (Mar 2023)

The correlation beteen lifestyle and risk of metabolic syndrome in schizophrenia

  • K. Krysta,
  • B. Tredzbor,
  • E. Martyniak,
  • K. Piekarska-Bugiel,
  • A. Koźmin-Burzyńska,
  • A. Cieślik,
  • M. Krzystanek

DOI
https://doi.org/10.1192/j.eurpsy.2023.2262
Journal volume & issue
Vol. 66
pp. S1066 – S1066

Abstract

Read online

Introduction Patients suffering from schizophrenia have a higher risk of premature death. An unhealthy lifestyle contributes to increased risk of cardiovascular diseases, metabolic syndromes, suicides among them. In addition to the use of selected therapy with a restriction metabolic risk has become important to influence non-pharmacological factors such as proper diet, introducing the principles of a healthy lifestyle. A diet rich in fiber, the DASH diet, the Mediterranean diet may become beneficial in terms of lowering parameters metabolic, cardiovascular and immune related to premature mortality in schizophrenia. Patients suffering from schizophrenia have a higher risk of premature death. An unhealthy lifestyle contributes to increased risk of cardiovascular diseases, metabolic syndromes, suicides among them. In addition to the use of selected therapy with a restriction metabolic risk has become important to influence non-pharmacological factors such as proper diet, introducing the principles of a healthy lifestyle. A diet rich in fiber, the DASH diet, the Mediterranean diet may become beneficial in terms of lowering parameters metabolic, cardiovascular and immune related to premature mortality in schizophrenia. Objectives The objective of this study was to evaluate the influence of the lifestyle on the metabolic parameters in schizophrenia Methods In our study, we assessed the influence of diet, nutritional knowledge and lifestyle on parameters of metabolic syndrome (cholesterol, triglicerydes, glucose) in patients with schizophrenia. Results In the results we have found positive co-relations between unhealthy diet and lifestyle and lack of knowledge on proper nutrition and increased parameters of metabolic syndrome. Groups BMI (Std. Dev) Cholesterol HDL mg/dl Triglicerides mg/dl Insuline resistanece Insuline uU/ml Study group 30,58(4,44) 45,63(7,34) 177,32(108,76) 4,68(4,64) 19.77(17,35) Control Group 26,00(3,39) 54,32(14,07) 111,47(57,48) 2,1(!,21) 9,01(4,97) Conclusions Dietary intervention may become one of the therapeutic goals in schizophrenia. Disclosure of Interest None Declared